Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflora Incarnata Extract in Partial Onset Epilepsy
NCT00982787Phase 2Withdrawn
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2009
- Primary completion
- Jan 2011
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of passiflora incarnata extract in partial epilepsy (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Seizure frequency at 32 weeks. Planned start Sep 2009; status: withdrawn.
02
Drugs
passiflora incarnata extract
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00982787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982787.